CM
ABEO icon

Caption Management’s Abeona Therapeutics ABEO Stock Holding History

Caption Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-435,000
Closed -$2.3M – 1520
2025
Q3 		$2.3M Sell
435,000
-557,300
-56% -$3.53M 0.02% 794
2025
Q2 		$5.64M Buy
+992,300
New +$5.65M 0.06% 366
2018
Q3 		– Sell
-1,000
Closed -$400K – 495
2018
Q2 		$400K Buy
+1,000
New +$437K 0.03% 333

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Caption Management's ABEO Position: Q1 2026 in Review

Caption Management reduced its Abeona Therapeutics (ABEO) stake by 91% in Q1 2026, selling an estimated $261K and leaving 4,874 shares worth $21.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1454.

Caption Management first reported a position in ABEO in Q3 2019 and has held it in 4 quarters since. The position peaked at $301K in Q4 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Caption Management held 4,874 shares of Abeona Therapeutics worth $21.8K as of Q1 2026.
  • Caption Management sold 52,157 Abeona Therapeutics shares in Q1 2026, an estimated $261K.
  • Abeona Therapeutics made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1454 holding.
  • Caption Management first reported a position in Abeona Therapeutics in Q3 2019 and has held it in 4 quarters since.
  • Caption Management's Abeona Therapeutics position peaked at $301K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.